bioxconomy.com
A podcast discussion about how toxic cone snails and a "combination of synthesis and structure" led one scientist into the world of peptide rese…
Appointments for CFO and finance for ATyr, Sanofi, Cue Biopharma, Levicept, City Therapeutics, Longeveron, Mayna Pharma, Nasus, Olema Oncology a…
Patients receiving teclistamab had a “71% lower risk of disease progression or death.”
Capital flows to differentiated biotech as M&A surges and IPO windows open for companies with clear execution strategies.
A joint research initiative between UCL and UCLA has produced a gene therapy with a 95% success rate and no safety concerns in multi-year follow…
In Boston, three distinguished awards showcase groundbreaking achievements shaping the future of IRT.